Potential role of phospholipases in virulence and fungal pathogenesis.

By M. Ghannoum. Clinical Microbiology Reviews, 2000

744 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

Candida albicans Secreted Aspartyl Proteinases in Virulence and Pathogenesis (2003, background): “0 (75, 182, 210, 247), this would allow for the concomitant expression of a number of similar SAP genes at environments with different pH values.”
Candida parapsilosis, an Emerging Fungal Pathogen (2008, background): “parapsilosis strains (101) and others finding no activity (128, 242, 253).”
Candida glabrata, Candida parapsilosis and Candida tropicalis: biology, epidemiology, pathogenicity and antifungal resistance. (2012, background): “Several studies indicate that NCAC species produce extracellular phospholipases (Furlaneto-Maia et al., 2007; Cafarchia et al., 2008; Galan-Ladero et al., 2010), but at significantly lower levels compared with C. albicans (Ghannoum, 2000).”
Candida species: current epidemiology, pathogenicity, biofilm formation, natural antifungal products and new therapeutic options. (2013, background): “Plb1p is an 84 kDa glycoprotein present at hyphal tips during tissue invasion and has hydrolase and lysophospholipase-transacylase activity (Ghannoum, 2000).”
Candida Infections of the Genitourinary Tract (2010, background): “albicans, PLB2 contributes in a minor way, because a PLB1-deficient strain still produces residual amounts of phospholipase B activity (103).”